Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||8.00||0.7%||$559.23m|
|GILD||Gilead Sciences, Inc.||-0.06%||64.85||1.0%||$472.13m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.27%||478.32||2.7%||$432.27m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.07%||216.10||1.9%||$372.34m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||153.73||2.0%||$315.33m|
|EXAS||EXACT Sciences Corp.||1.48%||129.89||18.4%||$197.74m|
|NBIX||Neurocrine Biosciences, Inc.||0.00%||92.97||4.9%||$172.50m|
|CRSP||CRISPR Therapeutics AG||0.47%||121.45||0.6%||$170.15m|
|TXG||10X Genomics, Inc.||0.00%||197.36||0.0%||$149.02m|
Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.